文献速递免疫规划传染病防控与疫情报告

在采用检测阴性设计的COVID-19疫苗有效性评估中考虑COVID-19与流感疫苗接种相关性的影响

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design.
PubMed 文献 · Vaccine · 2023-11-23

该研究利用多州VISION疫苗有效性网络数据,评估在检测阴性设计的COVID-19疫苗有效性(VE)研究中,考虑流感疫苗接种状态或纳入/排除流感阳性对照对二价疫苗VE估计的影响。分析涵盖2022年10月至2023年2月SARS-CoV-2与流感共同流行期间的就诊事件,结果显示COVID-19 VE估计稳健,大多数VE估计变化小于5个百分点。

要点

  • 考虑流感疫苗接种状态或纳入/排除流感阳性对照后,COVID-19 VE估计稳健,大多数变化小于5个百分点。
  • 对照中流感阳性患者比例较高、流感疫苗接种覆盖率或VE可能影响这些发现。
  • 潜在偏倚应继续评估。

核心结论

  • 考虑流感疫苗接种状态或纳入/排除流感阳性对照时,COVID-19 VE估计稳健,大多数VE估计变化小于5个百分点。

研究设计与样本

  • 利用多州VISION疫苗有效性网络数据,采用检测阴性设计,分析2022年10月至2023年2月SARS-CoV-2与流感共同流行期间的急诊/紧急护理就诊和住院事件。

主要发现

  • 当考虑流感疫苗接种状态或纳入/排除流感阳性对照时,针对COVID-19相关住院和急诊/紧急护理就诊的大多数VE估计变化小于5个百分点。

局限性

  • 对照中流感阳性患者比例较高、流感疫苗接种覆盖率或VE可能影响这些发现;潜在偏倚应继续评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Test-negative-design COVID-19 vaccine effectiveness (VE) studies use symptomatic SARS-CoV-2-positive individuals as cases and symptomatic SARS-CoV-2-negative individuals as controls to evaluate COVID-19 VE. To evaluate the potential bias introduced by the correlation of COVID-19 and influenza vaccination behaviors, we assessed changes in estimates of VE of bivalent vaccines against COVID-19-associated hospitalizations and emergency department/urgent care (ED/UC) encounters when considering influenza vaccination status or including or excluding influenza-positive controls using data from the multi-state VISION vaccine effectiveness network. Analyses included encounters during October 2022 - February 2023, a period of SARS-CoV-2 and influenza cocirculation. When considering influenza vaccination status or including or excluding influenza-positive controls, COVID-19 VE estimates were robust, with most VE estimates against COVID-19-associated hospitalization and ED/UC encounters changing less than 5 percentage points. Higher proportions of influenza-positive patients among controls, influenza vaccination coverage, or VE could impact these findings; the potential bias should continue to be assessed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Payne AB, Ciesla AA, Rowley EAK, et al. Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design. Vaccine. 2023. PMID: 38000964. doi:10.1016/j.vaccine.2023.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。